ASP3325 + Placebo
Phase 1CompletedDevelopment Stage
Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects
Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects
Jul 1, 2013 → Dec 1, 2013
About ASP3325 + Placebo
ASP3325 + Placebo is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects. The current trial status is completed. This product is registered under clinical trial identifier NCT02500953. Target conditions include Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects were approved
Hype Score Breakdown
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02500953 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects